Polymorphisms in the CCR5 Promoter Associated with Cervical Intraepithelial Neoplasia in a Chinese Han Population

Overview

Journal BMC Cancer

Publisher Biomed Central

Specialty Oncology

Date 2019 Jun 2

PMID 31151412

Citations 3

Authors

Shuyuan Liu

Jun Chen

Zhiling Yan

Shuying Dai

Chuanyin Li

YuFeng Yao

Li Shi

Affiliations

Soon will be listed here.

Abstract

Background: C-C chemokine receptor 5 (CCR5) has attracted wide concern for its critical role in the progression of human immunodeficiency virus type 1 (HIV-1) infection. Several studies have demonstrated that CCR5 affects the processes of tumor cell migration, invasion, and metastasis. The aim of this study was to illustrate the association between the polymorphisms of the CCR5 promoter and the development of cervical cancer.

Methods: 336 women with cervical intraepithelial neoplasia (CIN), 488 women with cervical cancer (CC), and 682 healthy controls were recruited to detect polymorphisms in the CCR5 promoter using a sequencing method.

Results: Six loci with polymorphism were found in the CCR5 promoter; the frequencies of the minor alleles of rs1799987 was significantly higher in the CIN group than that in the control group (P = 0.007); and the genotypic frequencies of rs2734648, rs1799987, rs1799988 and rs1800023 were significantly different between the CIN group and the control group (P < 0.008). The inheritance model analysis showed that rs2734648, rs1799987, rs1799988 and rs1800023 significantly increased the susceptibility to CIN in a recessive genetic model (P < 0.008). The haplotype constructed by the major alleles of these 6 SNPs (rs2227010-rs1799987-rs1799988-rs2734648-rs1800023-rs1800024: A-G-A-C-A-T) was highly protective against CIN (OR = 0.731, 95%CI: 0.603-0.886, P = 5.68E-03). In addition, transcription prediction showed that mutation of these 6 SNPs might alternate the binding of particular transcription factors.

Conclusion: The CCR5 promoter polymorphisms were significantly associated with cervical intraepithelial neoplasia by altering the expression of CCR5 on the cell surface in a Chinese Han population.

Citing Articles

The relationship between long non-coding gene polymorphisms and cervical cancer.

Han L, Liu J, Shataer M, Wu C, Niyazi M Cancer Biol Ther. 2024; 25(1):2322207.

PMID: 38465665 PMC: 10936591. DOI: 10.1080/15384047.2024.2322207.

Association of CCR5Δ32 Deletion and Human Cytomegalovirus Infection With Colorectal Cancer in Tunisia.

Chelbi H, Jelassi R, Belfkih S, Ben Amor A, Saidi N, Ben Salah H Front Genet. 2022; 12:598635.

PMID: 34976001 PMC: 8719653. DOI: 10.3389/fgene.2021.598635.

Promoter Polymorphisms Associated With Pulmonary Tuberculosis in a Chinese Han Population.

Liu S, Liu N, Wang H, Zhang X, Yao Y, Zhang S Front Immunol. 2021; 11:544548.

PMID: 33679683 PMC: 7935552. DOI: 10.3389/fimmu.2020.544548.

References

Kleeff J, Kusama T, Rossi D, Ishiwata T, Maruyama H, Friess H . Detection and localization of Mip-3alpha/LARC/Exodus, a macrophage proinflammatory chemokine, and its CCR6 receptor in human pancreatic cancer. Int J Cancer. 1999; 81(4):650-7. DOI: 10.1002/(sici)1097-0215(19990517)81:4<650::aid-ijc23>3.0.co;2-#. View

Blanpain C, Migeotte I, Lee B, Vakili J, Doranz B, Govaerts C . CCR5 binds multiple CC-chemokines: MCP-3 acts as a natural antagonist. Blood. 1999; 94(6):1899-905. View

Mummidi S, Bamshad M, Ahuja S, Gonzalez E, Feuillet P, Begum K . Evolution of human and non-human primate CC chemokine receptor 5 gene and mRNA. Potential roles for haplotype and mRNA diversity, differential haplotype-specific transcriptional activity, and altered transcription factor binding to polymorphic.... J Biol Chem. 2000; 275(25):18946-61. DOI: 10.1074/jbc.M000169200. View

Rossi D, Zlotnik A . The biology of chemokines and their receptors. Annu Rev Immunol. 2000; 18:217-42. DOI: 10.1146/annurev.immunol.18.1.217. View

Blanpain C, Lee B, Tackoen M, Puffer B, Boom A, Libert F . Multiple nonfunctional alleles of CCR5 are frequent in various human populations. Blood. 2000; 96(5):1638-45. View

Messeguer X, Escudero R, Farre D, Nunez O, Martinez J, Alba M . PROMO: detection of known transcription regulatory elements using species-tailored searches. Bioinformatics. 2002; 18(2):333-4. DOI: 10.1093/bioinformatics/18.2.333. View

Tindle R . Immune evasion in human papillomavirus-associated cervical cancer. Nat Rev Cancer. 2002; 2(1):59-65. DOI: 10.1038/nrc700. View

Farre D, Roset R, Huerta M, Adsuara J, Rosello L, Alba M . Identification of patterns in biological sequences at the ALGGEN server: PROMO and MALGEN. Nucleic Acids Res. 2003; 31(13):3651-3. PMC: 169011. DOI: 10.1093/nar/gkg605. View

Salkowitz J, Bruse S, Meyerson H, Valdez H, Mosier D, Harding C . CCR5 promoter polymorphism determines macrophage CCR5 density and magnitude of HIV-1 propagation in vitro. Clin Immunol. 2003; 108(3):234-40. PMC: 3728895. DOI: 10.1016/s1521-6616(03)00147-5. View

10.

Bream J, Young H, Rice N, Martin M, Smith M, Carrington M . CCR5 promoter alleles and specific DNA binding factors. Science. 2004; 284(5412):223. DOI: 10.1126/science.284.5412.223a. View

11.

Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira M, Bender D . PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007; 81(3):559-75. PMC: 1950838. DOI: 10.1086/519795. View

12.

Picton A, Paximadis M, Tiemessen C . Genetic variation within the gene encoding the HIV-1 CCR5 coreceptor in two South African populations. Infect Genet Evol. 2010; 10(4):487-94. PMC: 2877777. DOI: 10.1016/j.meegid.2010.02.012. View

13.

Arbyn M, Walker A, Meijer C . HPV-based cervical-cancer screening in China. Lancet Oncol. 2010; 11(12):1112-3. DOI: 10.1016/S1470-2045(10)70262-X. View

14.

Dupont W, Plummer Jr W . Power and sample size calculations. A review and computer program. Control Clin Trials. 1990; 11(2):116-28. DOI: 10.1016/0197-2456(90)90005-m. View

15.

Freitas A, Gurgel A, Chagas B, Coimbra E, do Amaral C . Susceptibility to cervical cancer: an overview. Gynecol Oncol. 2012; 126(2):304-11. DOI: 10.1016/j.ygyno.2012.03.047. View

16.

Schlecker E, Stojanovic A, Eisen C, Quack C, Falk C, Umansky V . Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth. J Immunol. 2012; 189(12):5602-11. DOI: 10.4049/jimmunol.1201018. View

17.

Aldinucci D, Colombatti A . The inflammatory chemokine CCL5 and cancer progression. Mediators Inflamm. 2014; 2014:292376. PMC: 3910068. DOI: 10.1155/2014/292376. View

18.

Ljubojevic S, Skerlev M . HPV-associated diseases. Clin Dermatol. 2014; 32(2):227-34. DOI: 10.1016/j.clindermatol.2013.08.007. View

19.

Sales K, Adefuye A, Nicholson L, Katz A . CCR5 expression is elevated in cervical cancer cells and is up-regulated by seminal plasma. Mol Hum Reprod. 2014; 20(11):1144-57. DOI: 10.1093/molehr/gau063. View

20.

Razmkhah M, Arabpour F, Taghipour M, Mehrafshan A, Chenari N, Ghaderi A . Expression of chemokines and chemokine receptors in brain tumor tissue derived cells. Asian Pac J Cancer Prev. 2014; 15(17):7201-5. DOI: 10.7314/apjcp.2014.15.17.7201. View